AlphAIalphai — Financial news for AI agents
yahoo.comAUG 192 min read$CAH

Cardinal Health’s (CAH) Big Earnings Beat Hides a More Complicated Story

Cardinal Health (CAH) reported Q4 2026 earnings with non-GAAP EPS up 40% YoY to $2.91, including a $0.31 one-time tariff refund. Revenue reached $63.7B, up 6% YoY. Full-year adjusted free cash flow hit $5B. Guidance suggests slower growth ahead. The company expanded its buyback program by $5B to $6.4B.

Original reporting
yahoo.com
Published Aug 19, 2026, 5:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 5:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Cardinal Health’s (CAH) Big Earnings Beat Hides a More Complicated Story — source image
Source · yahoo.com
Decision brief

The 30-second read

$CAHNeutralHigh
01

Why it matters

Earnings beat driven by non‑recurring tariff refund; guidance points to modest future growth, creating mixed signals for investors.

02

Market read

Earnings surprise may trigger short‑term buying, but guidance tempers expectations.

03

What to watch

Buyback expansion and Kroger contract extension provide longer‑term support.

Relevance 8/10Novelty 8/10Timing: post-earnings release

Background

Cardinal Health's Q4 FY2026 results were released on August 11, showing strong revenue growth and a sizable free cash flow increase.

Company-level read

Ticker impact

$CAHNeutralHigh confidence
Context

Cardinal Health reported Q4 FY2026 EPS of $2.91, a 40% YoY jump, driven partly by a one-time $100M tariff refund.

Expected impact

Potential modest upside on earnings beat, risk of pullback as guidance normalizes.

Evidence & confidence

Large cap with significant cash flow, but earnings boost includes non-recurring item; market may price in only incremental upside.

Market effects

Sector

Highlights strength in pharmaceutical distribution and gene‑therapy logistics, may benefit peers in health‑care distribution.

Regional

U.S. health‑care sector may see modest uplift.

Global

Limited to U.S. health‑care supply chain participants.

Counterpoint

What could challenge this read

One‑time tariff refund inflates EPS; guidance suggests slower growth, so price could correct.

Key entities

  • Company
    Cardinal Health

    U.S. health‑care distribution and services firm.

Read at source← All news

Related articles

AUG 18
$CAHHighAI 9/10

Cardinal Health (CAH) Q4 2026 Earnings Call Transcript

Cardinal Health (CAH) reported Q4 2026 revenue of $63.7B, up 6%, driven by Pharmaceutical and Specialty Solutions. Non-GAAP EPS was $2.91, up 40%. Fiscal 2027 guidance includes 3-5% pharma revenue growth and 8-11% profit growth. The company plans $1B in share repurchases and increased its authorization to $6.4B. Management cited risks from geopolitical instability and IRA price changes.

fool.com6 min
AUG 18
$CAHMed

5 Revealing Analyst Questions From Cardinal Health’s Q2 Earnings Call

Cardinal Health reported Q2 revenue of $63.67B, below Wall Street’s $65.42B estimate, but adjusted EPS of $2.60 beat the $2.42 estimate. Management cited demand in Pharmaceutical and Specialty Solutions and progress on its improvement plan in Global Medical Products and Distribution. Guidance for FY2027 adjusted EPS midpoint was $12.50. Analysts asked about specialty growth, M&A, regulatory impacts, and input costs.

financialcontent.com7 min
AUG 17
$BAXMed

Baxter’s interim CFO is leaving for Cardinal Health

Baxter said in SEC filings that interim CFO Anita Zielinski will leave in September. She will join Cardinal Health as chief accounting officer and SVP of finance on Nov. 5, with a $750,000 sign-on bonus and $1 million in time-vesting RSUs. Baxter has not named a successor. Baxter recently raised its full-year outlook to 3%-4% sales growth and adjusted EPS of $1.95-$2.15.

massdevice.com4 min
AUG 14
$CAHMed

Stronger Results, Bigger Buyback and More Credit Capacity Might Change The Case For Investing In Cardinal Health (CAH)

Cardinal Health (CAH) reported stronger Q4 and full-year results, with quarterly sales of US$63,672 million and quarterly net income of US$398 million, and expanded its revolving credit capacity to US$4.00 billion. The company authorized a new US$5.00 billion share repurchase program and declared a US$0.5158 quarterly dividend, while continuing product recall activity.

simplywall.st4 min
AUG 11
$CAHMedAI 8/10

Cardinal Health, Inc. Q4 2026 Earnings Call Summary

Cardinal Health’s fiscal 2026 performance was supported by resilient demand in Pharmaceutical and Specialty Solutions, with Specialty strength growing over 25% and a $100 million net nonrecurring GMPD tailwind from IEEPA tariff refunds. For fiscal 2027, it guided EPS of $12.40 to $12.60, with GMPD profit $200 million to $220 million, plus $700 million CapEx and at least $1 billion share repurchases.

yahoo.com6 min